Researchers at Peter MacCallum Cancer Centre have developed a digital phenotype to assist with automatically identifying ...

AbbVie today announced that the European Medicines Agency's Committee for Medicinal Products for Human Use (CHMP) has adopted a positive opinion recommending the approval of upadacitinib (RINVOQ®; 15 ...

Positive CHMP opinion is supported by data from the Phase 3 UP-AA clinical program in which upadacitinib achieved the primary endpoint of Severity of Alopecia Tool (SALT) score = 20 and key ...

By Puyaan Singh June 29 (Reuters) - Abivax said on Monday its experimental ulcerative colitis drug helped harder-to-treat groups of patients achieve remission, sending U.S.-listed shares of the ...

Andrew covers the biopharma industry, scientific research, and public health across the continent. You can reach Andrew confidentially on Signal at drewqjoseph.71. LONDON — Abivax on Monday night ...

Rates of malignancies and certain skin cancers in the trial remained in line with what is typically seen in people living with ulcerative colitis, the company said. ・This helps resolve certain earlier ...

SKYRIZI (risankizumab-rzaa) is now approved for patients six years of age and older with moderate-to-severe plaque psoriasis or active psoriatic arthritis Approval ...

The Rome V criteria for IBS identified a different group of patients, with lower sensitivity than either Rome III or IV ...

Evommune’s recent miss with EVO756's CSU indications is a major setback. Read why I think the selloff in EVMN stock is ...

Spyre Therapeutics is building a long-acting antibody platform across IBD and rheumatology. Read why I only rate SYRE stock a ...

Colon cancer used to feel like a worry for later-something to think about decades down the road. Not anymore. An estimated ...

Tresca is a writer and speaker who covers digestive conditions, including IBD. She was diagnosed with ulcerative colitis at age 16. Suzanne Fisher, RD, is a registered dietitian and licensed ...